Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.6 USD | -2.11% | -5.54% | +70.09% |
May. 08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
Financials (USD)
Sales 2024 * | 96.7M | Sales 2025 * | 117M | Capitalization | 509M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -26M | EV / Sales 2024 * | 4.15 x |
Net cash position 2024 * | 108M | Net cash position 2025 * | 127M | EV / Sales 2025 * | 3.26 x |
P/E ratio 2024 * |
-22.2
x | P/E ratio 2025 * |
-22.6
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.74% |
Latest transcript on Y-mAbs Therapeutics, Inc.
1 day | -2.11% | ||
1 week | -5.54% | ||
Current month | -23.73% | ||
1 month | -22.67% | ||
3 months | -28.79% | ||
6 months | +113.63% | ||
Current year | +70.09% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Gad
FOU | Founder | 54 | 15-03-31 |
Michael Rossi
CEO | Chief Executive Officer | 53 | Nov. 05 |
Bo Kruse
DFI | Director of Finance/CFO | 52 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Gill
BRD | Director/Board Member | 69 | 17-11-30 |
Director/Board Member | 54 | 15-08-31 | |
James Healy
CHM | Chairman | 59 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% | ||
0.01% | 430 M€ | -.--% | ||
0.01% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 11.6 | -2.11% | 379,958 |
24-05-16 | 11.85 | -2.71% | 207,629 |
24-05-15 | 12.18 | +3.05% | 267,473 |
24-05-14 | 11.82 | -3.04% | 427,141 |
24-05-13 | 12.19 | -0.73% | 543,801 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.09% | 509M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- YMAB Stock